Abstract Available data have demonstrated important sex-related differences in patients with valvular heart disease, regarding clinical presentation, treatment, and outcomes. Although the calcific aortic stenosis (AS) is more frequent in men compared to women, the majority of AS patients over 80 years old are women, in whom fibrotic remodeling of aortic valve is typically found. Mitral valve disease is more common in women. However females are under-referred or delayed referrals to treatment, probably due to the absence of sex-based LV dimension values guiding surgical timing. The development of transcatheter devices have revolutionized the treatment of valvular heart disease and increased the interest in this topic. In this context, the consideration of gender differences in presentation, diagnosis, treatment success, and prognosis is of great importance. Copyright ©2023 Heart, Vessels and Transplantation.

Aurigemma, C., Burzotta, F., Trani, C., Heart valve disease gender difference in the era of transcatheter treatment, <<HEART, VESSELS AND TRANSPLANTATION>>, 2023; 7 (2): N/A-N/A. [doi:10.24969/hvt.2023.375] [https://hdl.handle.net/10807/268455]

Heart valve disease gender difference in the era of transcatheter treatment

Aurigemma, Cristina;Burzotta, Francesco;Trani, Carlo
2023

Abstract

Abstract Available data have demonstrated important sex-related differences in patients with valvular heart disease, regarding clinical presentation, treatment, and outcomes. Although the calcific aortic stenosis (AS) is more frequent in men compared to women, the majority of AS patients over 80 years old are women, in whom fibrotic remodeling of aortic valve is typically found. Mitral valve disease is more common in women. However females are under-referred or delayed referrals to treatment, probably due to the absence of sex-based LV dimension values guiding surgical timing. The development of transcatheter devices have revolutionized the treatment of valvular heart disease and increased the interest in this topic. In this context, the consideration of gender differences in presentation, diagnosis, treatment success, and prognosis is of great importance. Copyright ©2023 Heart, Vessels and Transplantation.
2023
Inglese
Aurigemma, C., Burzotta, F., Trani, C., Heart valve disease gender difference in the era of transcatheter treatment, <<HEART, VESSELS AND TRANSPLANTATION>>, 2023; 7 (2): N/A-N/A. [doi:10.24969/hvt.2023.375] [https://hdl.handle.net/10807/268455]
File in questo prodotto:
File Dimensione Formato  
375.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 496.39 kB
Formato Adobe PDF
496.39 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/268455
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact